Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
Focused on digital therapeutics for heart disease.The #1 cause of death in the world.
$300B market in the US.
All players have solutions for heart health, but none of them
really work since they are not engaging
Source: Cleveland clinic survey 2013, AHA Heart disease and stroke statistics update, 2015
Track and understand all of your heart health factors
Catch hypertenisve crisis and irregular heartbeat risks in time
Personalized AI-driven digital coaching reduces BP
Using AI and UX excellence, we built a purely digital solution that gets people engaged
Source: Uhlig, K., (2012). Self-Measured Blood Pressure Monitoring: Comparative Effectiveness. Agency for Healthcare Research and Quality (US). A retrospective data study completed by doctors from UCLA and Harvard showed high engagement in the Hello Heart app. It determined a correlation between user engagement and reduction in self-reported blood pressure readings. “Improving patient engagement in self-measured blood pressure monitoring using a mobile health technology.” Alan L. Kaplan, Erica R. Cohen, Eyal Zimlichman. Expected publication December 2018. Users who recorded
more than 10 BP readings were included in the analysis.
And it works. Hello Heart is clinically-validated with unbeatable outcomes. X2 better than any other solution.
Average decrease of systolic blood pressure per method
Hello Heart’sSolution
22 mmHg
Disease management programs, Omada & Livongo
4-10 mmHg
Remote patient monitoring
2-4 mmHg 70% reduced blood pressure and heart risk.
Published peer-reviewed study:
Outcomes demonstrated in a peer review study:
22 points reduction mmHg Systolic blood pressure reduction after 12 months
70%Of users reduced blood pressure.
34%Reduction in cardiac claims in 1 year.
Best in class clinical outcomes.
1 - Evive study for a jumbo retailer on Hello Heart clinical outcomes and ROI; 2 - Hello Heart UCLA Harvard peer reviewed study, 2017(3),(4) &(5) https://www.cdc.gov/bloodpressure/facts.htm
(6) https://healthpayerintelligence.com/news/top-10-most-expensive-chronic-diseases-for-healthcare-payers
Recognized as best in class by:
A purely digital solution. Attractive deal economics and very high margins.
● We sell mainly to large self-insured employers
● B2B2C: Per participant per month pricing model
● 3 year/evergreen contracts with expansion opportunity
Currentdeal size:
$200K-$10M
Hello Heart is a software-only solution which generates high margins of +70%.
Committed accumulated Annual Recurring Revenue (CARR) have tripled Y-Y
Jan 2017 Jan 2018 Jan 2019 Jan 2020x3 Jan 2021
32 F500 clients1.5M covered lives
x3 x3 x3
Hello Heart is scaling rapidly.
● CVS caremark is the biggest channel of digital therapeutics with 93M
lives. After a rigorous clinical review, CVS selected Hello Heart to be
included in their digital formulary of best in class solutions (point
solutions management).
● CVS is now offering Hello Heart to
their PBM clients. First channel
clients launched in 1/1/21.
● Hello Heart can now also bill via
claims and is setup with United,
Cigna, and Anthem.
Channel dominance is key in scaling. Hello Heart is now offered by CVS Caremark.
Road map: Best in class in hypertension expanding to “whole heart” diagnosis and management tools.
Arrhythmia Hypertension andirregular heartbeat
Hyperlipidemia
Cholesterol and triglycerides tracking from 99% of EMRs
FDA approved ECG to manage Arrhythmia, detects life threatening
bradycardia and tachycardia
Road map: Deepening AI capabilities to sustain our competitive advantage of unbeatable clinical outcomes
AI Hooked
Loyal
Influenced
Not Engaged
Experienced Leadership team, scaling confidently.
Amy GouldHead of Talent Acquisition
Orit WohlHead of Product Marketing
Ziv MeltzerChief Design & UX Officer
Sue GiordanoHead of Client Experience
Jesús BermúdezChief Growth Officer
Jessica WithersHead of People
Scaled Best doctors to +200 clients with 95%
retention rate
Maayan CohenCEO
Regis HaeglerVP of Finance
Tom KahlCRO
Michal GutmanCTO & CISO
Scaled Grand rounds from 20M to X10 in Revenue